ALB
Albemarle Corporation
$156.69
▼ 2.3%Updated Today 7:15 PM ET
▲ Up 169.9% over the last 12 months
Market Cap
$18.91B
P/E
—
Forward P/E (est.)
—
ROE
-2.4%
Revenue Growth
7.9%
EPS Growth
—
Profit Margin
-4.2%
FCF Yield
10.6%
Debt / Equity
0.34x
ROIC
-2.0%
Interest Coverage
—
Current Ratio
2.07x
Dividend Yield
1.0%
Implied Growth (rev. DCF)
5.1%
Rating Score
40/100
Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what ALB's chart says today, with each tool explained.
Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. ALB trades near $156.69, around its 50-day average ($181.19) and 200-day average ($146.14). Price tangled in its moving averages means there is no clear trend — the stock is ranging.
Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 39 it is in neutral territory — neither stretched nor washed out.
MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently positive — short-term momentum is improving.
Volatility — ATR. Average True Range is the typical daily move. ALB's is $8.69 (~5.5% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.
Support & resistance. Over the last month ALB found buyers near $146.76 (support) and sellers near $180.26 (resistance); its 52-week range is $55.90–$221.00. A decisive break beyond either edge often marks the next move.
Volume. The latest session traded 1.9× the 20-day average — heavier than usual, which adds conviction to the move. Rising volume on up-days suggests real buying; on down-days, real selling.
Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.
Albemarle Corporation (ALB) is a large-cap company in the Specialty Chemicals industry, part of the Materials sector of the S&P 500, with a market value around $18.91B.
In its latest reported year it generated about $5.14B in revenue and posted a net loss of $510.63M.
Our model rates ALB Weak (40/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
4Y CAGR
11.5%
Revenue moved from $3.33B in 2021 to $5.14B in 2025, a 11.5% compound annual growth rate. The most recent year grew a steady 7.9% year over year. Slower, mature growth is common for established businesses.
Gross Margin
13.0%
Operating Margin
-7.1%
Net Margin
-9.9%
ROE
-2.4%
Albemarle Corporation keeps about -4.2% of each sales dollar as net profit, with a 13.0% gross margin and -7.1% operating margin. Return on equity is -2.4% and return on invested capital about -2.0%. The company is currently unprofitable on a net basis.
Total Debt
$1.88B
Net Debt
$792.02M
Net Debt / EBITDA
—
Debt / Equity
0.34x
Leverage: debt-to-equity is 0.3x, with a current ratio of 2.1x. That is a conservative balance sheet — a cushion in downturns. It carries roughly $1.88B of total debt against $1.09B of cash.
Operating CF
$1.28B
Free Cash Flow
$692.47M
FCF Margin
13.5%
In the latest year Albemarle Corporation produced about $1.28B of operating cash flow and $692.47M of free cash flow after capital spending. That is a free-cash-flow yield of about 10.6% on today's price. Strong cash generation funds dividends, buybacks, and reinvestment.
P/E
—
P/S
3.8x
P/B
1.69x
EV / EBITDA
69.9x
ALB trades at n/a trailing earnings, 3.8x sales, and 1.7x book value. Reverse-engineering today's price implies the market expects roughly 5.1% long-term free-cash-flow growth. With no positive trailing earnings, value it on sales, cash flow, or growth rather than P/E.
Where this stock sits versus what most companies trade at.
Typical ranges are general references (e.g., many stocks trade at ~18–26x earnings), not hard rules. Context only — not investment advice.
How ALB stacks up against its Materials peers — valuation, profitability, and growth versus the sector median.
In the Materials sector (26 S&P 500 companies), ALB ranks #19 of 26 by our overall rating.
P/E vs sector
—
median 27.7x
ROE vs sector
-2.4%
median 14.1%
Growth vs sector
7.9%
median 4.9%
Sector rank
#19
of 26 by rating
Valuation vs. quality map
The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.
Peers are the closest Materials companies by sub-industry and size. Sector median is across all 26 S&P 500 names in the sector. Educational, not a recommendation.
Project revenue → earnings → price. Edit the assumptions to build your own case.
2030 price target (Base Case)
$23.07 – $38.44
vs. $156.69 today · expected CAGR -32% – -24%
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | $5.55B | $6.00B | $6.48B | $7.00B | $7.56B |
| Net income | $166.62M | $179.95M | $194.35M | $209.90M | $226.69M |
| EPS | $1.41 | $1.53 | $1.65 | $1.78 | $1.92 |
| Share price (low) | $16.95 | $18.31 | $19.78 | $21.36 | $23.07 |
| Share price (high) | $28.26 | $30.52 | $32.96 | $35.60 | $38.44 |
| CAGR (low–high) | -89% / -82% | -66% / -56% | -50% / -41% | -39% / -31% | -32% / -24% |
Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.
The case for ALB:
- Healthy free-cash-flow yield (~10.6%) funds buybacks and dividends.
- A conservative balance sheet (debt/equity 0.3x) lowers risk.
The case against ALB:
- Thin net margins (-4.2%) leave little room for error.
- Our model's overall read is Weak (40/100).
Margin risk — thin profitability (-4.2%) is vulnerable to cost or pricing pressure.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
On balance, the fundamentals screen weakly: Albemarle Corporation is a large-cap materials business growing at a mature pace, with modest profitability, and a sound balance sheet. It trades at n/a earnings, which our model scores Weak (40/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.